CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature

Autor:	Anthony E. Shrimpton, Srivalli Gopaluni, Raiza Perzova, Robert E. Hutchison, Lynn Abbott, Bernard J. Poiesz, Ramsey Farah
Rok vydání:	2008
Předmět:	Male medicine.medical_specialty Simvastatin Skin Neoplasms Tetrahydronaphthalenes Antineoplastic Agents Hyperlipidemias CD8-Positive T-Lymphocytes Neoplasms Multiple Primary Cd8 t lymphocyte Mycosis Fungoides Hypothyroidism immune system diseases hemic and lymphatic diseases Internal medicine medicine Humans Carcinoma Renal Cell Hypolipidemic Agents Bexarotene Incidental Findings Hematology business.industry Contraindications Cutaneous T-cell lymphoma Bexaroteno Exanthema Middle Aged medicine.disease Ezetimibe Kidney Neoplasms Lymphoma CTL Thyroxine Immunology Cancer research Azetidines Hydroxymethylglutaryl-CoA Reductase Inhibitors business CD8 medicine.drug
Zdroj:	American journal of hematology. 83(9)
ISSN:	1096-8652
Popis:	CD8+ cutaneous T-cell lymphoma (CTCL) is a relatively rare subset of the non-Hodgkins lymphomas. Bexarotene has been FDA-approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report on a patient whose CD8+ CTCL completely responded to treatment with bexarotene.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e96c268df9668f1d60b46cc90709e14 https://pubmed.ncbi.nlm.nih.gov/18615708 Zobrazit plný text záznamu Plný text